From Name

From Email

To Name

To Email

Message

Children with COVID-19 to Be Enrolled in Remdesivir Clinical Trial, Drugmaker Says

from NBC News

Children with COVID-19 to Be Enrolled in Remdesivir Clinical Trial, Drugmaker Says NBC News Drugmaker Gilead Sciences said recently it will soon begin enrollment of pediatric patients with moderate-to-severe COVID-19 in a late-stage study testing its experimental drug, remdesivir. The trial will assess the effectiveness and safety of the drug in the patients, which would include newborns to adolescents, across more than 30 sites in the U.S. and Europe, the company said. READ MORE

more